Gemcitabine in the Treatment of Relapsed and Refractory Hodgkin’s Disease

Publisher： Karger

E-ISSN： 2296-5262|28|11|567-571

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.28, Iss.11, 2005-10, pp. : 567-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

By  

Acta Haematologica, Vol. 110, Iss. 4, 2003-12 ,pp. : 173-178

Karger

Access to resources Recommend Favorite

Treatment of Advanced Stage Hodgkin’s Disease

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 101-109

Karger

Access to resources Recommend Favorite

Is the Treatment of Hodgkin’s Disease Detrimental to the Parathyroid Gland?

By  

Acta Haematologica, Vol. 112, Iss. 3, 2004-09 ,pp. : 148-151

Karger

Access to resources Recommend Favorite

Systemic to Pulmonary Fistulas in Hodgkin’s Disease

By  

Respiration, Vol. 67, Iss. 4, 2000-07 ,pp. : 453-455

Karger

Access to resources Recommend Favorite

Synchronous Hodgkin’s Disease and Gastric Adenocarcinoma

By  

Oncology, Vol. 73, Iss. 5-6, 2008-06 ,pp. : 422-425

Karger

Access to resources Recommend Favorite